Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimerism”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Not applicableUnknownNCT05905770
What this trial is testing

Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)Study completedNCT01036009
What this trial is testing

Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 43
Early research (Phase 1)Ended earlyNCT02370888
What this trial is testing

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
University of Florida 11
Testing effectiveness (Phase 2)Study completedNCT00005801
What this trial is testing

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT01780454
What this trial is testing

Renal Allograft Tolerance Through Mixed Chimerism

Who this might be right for
End Stage Renal Disease
Massachusetts General Hospital 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05357482
What this trial is testing

Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia

Who this might be right for
Sickle Cell AnemiaBeta Thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 40
Not applicableStudy completedNCT00400192
What this trial is testing

Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury

Who this might be right for
ChimerismBlood TransfusionWounds and Injuries
Vitalant Research Institute 451
Early research (Phase 1)Study completedNCT02314403
What this trial is testing

Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)

Who this might be right for
Kidney Failure, ChronicRenal Insufficiency
Massachusetts General Hospital 2
Testing effectiveness (Phase 2)WithdrawnNCT01649388
What this trial is testing

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

Who this might be right for
Kidney Transplantation
Talaris Therapeutics Inc.
Large-scale testing (Phase 3)Study completedNCT01019876
What this trial is testing

Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureOsteopetrosisFanconi Anemia+1 more
Columbia University 38
Testing effectiveness (Phase 2)Looking for participantsNCT04008368
What this trial is testing

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels

Who this might be right for
Myeloid Chimerism
National Heart, Lung, and Blood Institute (NHLBI) 32
Testing effectiveness (Phase 2)Ended earlyNCT02963064
What this trial is testing

JSP191 Antibody Targeting Conditioning in SCID Patients

Who this might be right for
SCID
Jasper Therapeutics, Inc. 23
Not applicableStudy completedNCT03689907
What this trial is testing

Early Chimerism Following Allogeneic Stem-Cell Transplant

Who this might be right for
Allogeneic Stem-Cell Transplant
Dartmouth-Hitchcock Medical Center 40
Not applicableLooking for participantsNCT06856226
What this trial is testing

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaHematologic Malignancy
National Cancer Institute (NCI) 88
Not applicableUnknownNCT03101423
What this trial is testing

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

Who this might be right for
Beta Thalassemia Major
First Affiliated Hospital of Guangxi Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00029393
What this trial is testing

Induction of Stable Chimerism for Sickle Cell Anemia

Who this might be right for
Blood DiseaseHematopoietic Stem Cell TransplantationAnemia, Sickle Cell
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)UnknownNCT00603330
What this trial is testing

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Who this might be right for
Graft-versus-host DiseasePoor Graft FunctionLow Donor T-cell Chimerism
University of Liege 100
Not applicableNot Yet RecruitingNCT07607327
What this trial is testing

Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)

Who this might be right for
AML (Acute Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)CMML
CareDx 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT03077542
What this trial is testing

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 57
Load More Results